ストックスクリーナーアプリを入手
41.41
2.95%
1.1556
Rigel Pharmaceuticals (RIGL) 最新ニュース
Rigel awards new hires 13,375 RSUs under its inducement plan - Stock Titan
RI2 Forecast — Price Target — Prediction for 2027 - TradingView
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Sahm
Rigel Pharmaceuticals, Inc. Files 8-K With SEC: Corporate Details, Stock Info, and Compliance Updates - Minichart
Rigel appoints Alison L Hannah as chief medical officer - MSN
Alison Hannah joins Rigel (NASDAQ: RIGL) as new EVP and Chief Medical Officer - Stock Titan
Rigel Pharmaceuticals Appoints Dr. Alison L. Hannah as CMO (RIGL) - GuruFocus
Rigel Pharmaceuticals Appoints Alison L. Hannah as Chief Medical Officer - citybiz
Press Release: Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Moomoo
(RIGL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
RIGL Q1 2026 Earnings: EPS Misses Estimates, Revenue Not Disclosed, Stock Edges HigherRetail Earnings Report - dars.gov.et
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS: RIGL) added to Russell 2000 Value Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS: RIGL) added to Russell 3000E Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BX:RIGL - TradingView
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
RIGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
A40EFY Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to book forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBITDA forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Rigel Pharmaceuticals Inc (RIGL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Rigel Pharmaceuticals, Inc. Actuals & Estimates (DUS:RI2) - TradingView
Rigel Pharmaceuticals (RIGL) Short Interest & Short Float | Updated Jun 2026 $RIGL - MarketBeat
Form 4 Rigel Pharmaceuticals Inc For: 24 June By Investing.com - Investing.com Nigeria
Rigel Pharmaceuticals director Ali-Jackson Kamil sells $87,500 in stock By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals director Ali-Jackson Kamil sells $87,500 in stock - Investing.com
Rigel (RIGL) director sells 2,500 shares under 10b5-1 plan for tax withholding - Stock Titan
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Rigel Pharmaceuticals (RIGL) CEO gets 31,700 performance-based options - Stock Titan
Rigel (RIGL) CFO’s 7,394-share performance-based stock option fully vests - Stock Titan
RIGEL (RIGL) EVP granted 7,394 fully vested performance stock options - Stock Titan
Rigel (NASDAQ: RIGL) EVP granted 7,394 fully vested performance options - Stock Titan
Form 144 RIGEL PHARMACEUTICALS INC For: 22 June By Investing.com - Investing.com South Africa
[144] RIGEL PHARMACEUTICALS INC SEC Filing - Stock Titan
Rigel Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Rigel (RIGL) CMO Lisa Rojkjaer has performance-based options fully vest - Stock Titan
RIGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL) - Seeking Alpha
Liquidity Mapping Around (RIGL) Price Events - Stock Traders Daily
Rigel Expands Oncology Portfolio with VEPPANU Global Rights - The Globe and Mail
Rigel Pharmaceuticals Inc (RIGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rigel Pharmaceuticals secures rights to develop and market VEPPANU under new agreement - Traders Union
Rigel Pharmaceuticals Inc (RIGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
1.26%
3.59%
大文字化:
|
ボリューム (24 時間):